At the 10th Microbiome Movement Summit, we provide a premier platform for showcasing your cutting-edge solutions and expertise. Engage with senior-level decision-makers from leading biopharma companies, including Ferring Pharmaceuticals, Pulmobiotics, MaaT Pharma, Microviable Therapeutics, and Seres Therapeutics. This summit presents an unmatched opportunity for service providers to engage with an industry-focused senior audience of drug developers pioneering the next wave of microbiome-based therapies.
By delivering innovative tools and expertise for key processes, such as advancing microbiome sequencing and bioinformatics, enhancing preclinical research models, and optimizing clinical trials for microbiome-based therapies, your organization will be the go-to partner for biopharma drug developers and researchers working on active preclinical and clinical microbiome drug candidates.
With opportunities to present, network one-on-one with industry leaders, and enhance your brand visibility, explore a tailored partnership package that aligns with your strategic objectives, ensuring your innovations take center stage in the advancement of microbiome therapeutics
R&D Leaders in Microbiome Therapeutics are Actively Seeking
New Collaborations to:
Advance Microbiome Sequencing and Bioinformatics:
Develop cutting-edge technologies and bioinformatics tools for comprehensive sequencing and data analysis of microbiome profiles, aiding in the discovery of new therapeutic targets and predictive biomarkers for microbiome-related diseases.
Provide End-to-End Manufacturing Solutions:
Offer specialized contract manufacturing and development services to scale microbiome-based drug products, ensuring consistency, quality, and regulatory compliance from research to market.
Enhance Preclinical Research Models:
Deliver in vivo and in vitro preclinical research services, including specialized microbiome models, to evaluate the therapeutic potential and safety of microbiome-based interventions before clinical trials.
Optimize Clinical Trials for Microbiome Therapies:
Provide comprehensive clinical trial management services, including patient stratification, trial design, and data analysis, tailored to the unique challenges of microbiome drug development to ensure robust clinical evidence for therapeutic efficacy.
Support Microbiome Research with High-Quality Reagents and Biobanks:
Supply essential reagents, culture systems, and biobank services to facilitate the collection, preservation, and analysis of microbiome samples for drug development and clinical studies.
and more!
Why Partner?
Who Will You Meet?
2025 Partners:
